MANCARELLA, CATERINA
 Distribuzione geografica
Continente #
EU - Europa 351
NA - Nord America 313
AS - Asia 95
AF - Africa 14
SA - Sud America 2
OC - Oceania 1
Totale 776
Nazione #
US - Stati Uniti d'America 311
IT - Italia 130
DE - Germania 64
GB - Regno Unito 46
VN - Vietnam 40
SE - Svezia 36
CH - Svizzera 26
CN - Cina 21
SG - Singapore 16
IE - Irlanda 14
IN - India 11
BG - Bulgaria 9
FR - Francia 9
RU - Federazione Russa 7
TG - Togo 7
JO - Giordania 4
EE - Estonia 3
ZA - Sudafrica 3
CA - Canada 2
CI - Costa d'Avorio 2
NG - Nigeria 2
NL - Olanda 2
PK - Pakistan 2
UA - Ucraina 2
AU - Australia 1
BE - Belgio 1
CL - Cile 1
GR - Grecia 1
HK - Hong Kong 1
PE - Perù 1
PL - Polonia 1
Totale 776
Città #
Fairfield 43
Chandler 42
Southend 41
Frankfurt am Main 34
Bern 26
Bologna 26
Ashburn 22
Ann Arbor 20
Dong Ket 20
Cambridge 19
Woodbridge 15
Dublin 14
Florence 14
Princeton 12
Seattle 12
Wilmington 12
Singapore 11
Houston 9
Sofia 9
Bremen 7
Lomé 7
New York 7
Turin 6
Nanjing 5
Amman 4
Beijing 4
Berlin 4
Rome 4
Boydton 3
Francavilla Al Mare 3
Jinan 3
Los Angeles 3
Milan 3
Paris 3
Reggio Emilia 3
Reggio Nell'emilia 3
Shenyang 3
Westminster 3
Abeokuta 2
Abidjan 2
Amsterdam 2
Bellaria-Igea Marina 2
Cagliari 2
Fusignano 2
Giavera del Montello 2
Lahore 2
London 2
Mülheim 2
Naples 2
Norwalk 2
Padova 2
Ravenna 2
San Diego 2
San Gavino Monreale 2
Siderno 2
Siena 2
Verona 2
Ancona 1
Bruges 1
Bühl 1
Caserta 1
Castenaso 1
Chincha Alta 1
Crocetta 1
Des Moines 1
Guangzhou 1
Hebei 1
Hounslow 1
Hyderabad 1
Jiaxing 1
Medford 1
Montesarchio 1
Ningbo 1
Parma 1
Phoenix 1
Richmond 1
Riva 1
Saint Petersburg 1
Saint-Gely-du-Fesc 1
San Jose 1
San Pietro In Casale 1
Serio 1
Taizhou 1
Tianjin 1
Vanderhoof 1
Wanchai 1
Warsaw 1
Totale 547
Nome #
Integrated molecular characterization of patient-derived models reveals therapeutic strategies for treating CIC-DUX4 sarcoma 156
Metformin as an adjuvant drug against pediatric sarcomas: hypoxia limits therapeutic effects of the drug. 116
Abstract 3201: Insulin-like growth factor 2 (IGF-2) mRNA binding protein 3 predicts poor prognosis and promotes cell proliferation in Ewing sarcoma 114
Insulin-like growth factor 2 mRNA-binding protein 3 is a novel post-transcriptional regulator of Ewing sarcoma malignancy 113
Identification of common and distinctive mechanisms of resistance to different anti-IGF-IR agents in Ewing's sarcoma 100
Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 Modulates Aggressiveness of Ewing Sarcoma by Regulating the CD164-CXCR4 Axis 78
ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis 48
Polymorphic variants of IGF2BP3 and SENCR have an impact on predisposition and/or progression of Ewing sarcoma 44
Correction to: ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis 38
Totale 807
Categoria #
all - tutte 2.502
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.502


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020111 11 3 0 4 14 13 15 16 21 7 6 1
2020/202176 12 0 2 8 0 4 0 4 11 4 0 31
2021/2022169 25 0 4 2 10 5 1 21 15 19 45 22
2022/2023297 17 23 12 39 25 25 10 16 38 9 45 38
2023/2024108 9 22 10 13 9 18 5 8 4 5 0 5
2024/202517 17 0 0 0 0 0 0 0 0 0 0 0
Totale 807